Precision BioSciences Inc (DTIL)
7.26
+0.76
(+11.69%)
USD |
NASDAQ |
Nov 22, 14:33
Precision BioSciences Total Liabilities (Quarterly): 88.39M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 88.39M |
| June 30, 2024 | 91.09M |
| March 31, 2024 | 147.54M |
| December 31, 2023 | 140.92M |
| September 30, 2023 | 135.28M |
| June 30, 2023 | 147.66M |
| March 31, 2023 | 164.32M |
| December 31, 2022 | 177.74M |
| September 30, 2022 | 187.35M |
| June 30, 2022 | 194.14M |
| March 31, 2022 | 111.69M |
| December 31, 2021 | 120.33M |
| Date | Value |
|---|---|
| September 30, 2021 | 125.76M |
| June 30, 2021 | 129.56M |
| March 31, 2021 | 203.49M |
| December 31, 2020 | 105.73M |
| September 30, 2020 | 104.86M |
| June 30, 2020 | 98.59M |
| March 31, 2020 | 99.17M |
| December 31, 2019 | 96.92M |
| September 30, 2019 | 104.51M |
| June 30, 2019 | 97.94M |
| March 31, 2019 | 155.97M |
| December 31, 2018 | 98.64M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
88.39M
Minimum
Sep 2024
203.49M
Maximum
Mar 2021
133.53M
Average
127.66M
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 126.92B |
| Assembly Biosciences Inc | 74.26M |
| Protagonist Therapeutics Inc | 71.94M |
| Alector Inc | 397.09M |
| Entrada Therapeutics Inc | 132.14M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 153.26M |
| Shareholders Equity (Quarterly) | 64.87M |
| Debt to Equity Ratio | 0.3434 |
| Current Ratio | 9.224 |
| Net Debt Paydown Yield | 0.01% |